SARS CoV-2 escape variants exhibit differential infectivity and neutralization sensitivity to convalescent or post-vaccination sera

Research output: Other contribution

Original languageEnglish GB
PublisherNewsRX LLC
StatePublished - 2021

Keywords

  • Exhibitions
  • Pharmaceutical industry
  • Health aspects
  • Vaccination

Cite this